Stay updated on bb21217 Efficacy in Myeloma Clinical Trial

Sign up to get notified when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the bb21217 Efficacy in Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    - Added a MedlinePlus Genetics related topics entry for 'Multiple myeloma' on the page.
    Difference
    0.2%
    Check dated 2025-11-11T03:34:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The related topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics'. This is a minor labeling change that does not affect the trial's details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:57:02.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics related topics: Multiple myeloma resource link to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2025-10-27T21:11:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    - Removed a MedlinePlus Genetics topic on multiple myeloma, narrowing the page's coverage of genetics resources for this disease.
    Difference
    0.3%
    Check dated 2025-10-20T17:27:16.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic on multiple myeloma to the page, expanding core content related to genetics and disease.
    Difference
    0.3%
    Check dated 2025-10-13T12:32:30.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Significant additions include a status notice about government funding and operating status, new topic and organization mentions (MedlinePlus Genetics topic: Multiple myeloma; Genetix Biotherapeutics Inc.), and a software revision update (Revision: v3.2.0). The deletions remove bluebird bio and an older revision (v3.1.0). Overall, there is an important update to operating status and new entities/subjects; the removal of a competitor/entity and an older version is also notable.
    Difference
    5%
    Check dated 2025-10-06T08:30:40.000Z thumbnail image

Stay in the know with updates to bb21217 Efficacy in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.